Bradley Z. Naifeh Inaugural Amyloidosis Conference - Medical Professionals - LIVESTREAM (VIRTUAL ONLY)

March 3, 2023

LIVESTREAM (virtual) attendance

Houston Methodist J.C. Walter Conference Series

Presented by: Bradley Z. Naifeh Amyloidosis Clinical Research and Treatment Program at Houston Methodist J.C. Walter Jr. Transplant Center

Amyloidosis is an underrecognized condition because it has been historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics has made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.

FEES

REGISTRATION TYPEFEE
Physician (HM, MPAQ, ACO PCP) Complimentary
Physician (Private physician located within the Greater Houston Area)$230
Physician (Private physician located within the Greater Houston Area; NO CE) Click here to register!Complimentary
Physician (Private physician located outside the Greater Houston Area)Complimentary
Allied Health Care Professionals Complimentary
Resident / Fellow / Student Complimentary

* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.

Target Audience

Cardiologists, hematologists, neurologists. nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities.

Learning Objectives

Upon completion of this course, the participant should be able to:

  • Discuss the two major kinds (AL and TTR) of amyloidosis and appropriate diagnosis and categorization of these kinds.
  • Identify how to investigate the various organ involvement in Amyloidosis.
  • Discuss the current approved therapies for the two major kinds of amyloidosis (AL and TTR).
  • Describe the potential future therapies for both TTR and AL amyloidosis.
Course summary
Available credit: 
  • 4.75 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 4.75 Attendance
  • 5.00 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 5.00 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

  • 4.00 Social Work
    The program has been approved for 4.00 CE contact hours for Social Workers through the Texas State Board of Social Work Examiners.
  • 0.00 Transplant Coordinators
    The American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Bradley Z. Naifeh Inaugural Amyloidosis Conference - Medical Professionals - LIVESTREAM (VIRTUAL ONLY) | Tue, 01/03/2023 - 8:00am | 0.00 Category 1 CEPTCs
Course opens: 
01/03/2023
Course expires: 
04/03/2023
Event starts: 
03/03/2023 - 8:00am CST
Event ends: 
03/03/2023 - 3:15pm CST
Cost:
$230.00
TimePresentationSpeaker(s)
8:00 AMLeadership Welcome: Mission of the Transplant CenterR. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed)
8:05 AMConference IntroductionCo-Directors
Arvind Bhimaraj, MD, MPH, FACC, FHFSA
Barry H. Trachtenberg, MD, FACC
8:10 AMHistory of Amyloidosis Treatment in the Transplant CenterA. Osama Gaber, MD, FACS, FAST
8:15 AMIntroduction of the Bradley Z. Naifeh Amyloidosis ProgramArvind Bhimaraj, MD, MPH, FACC, FHFSA
8:20 AMSpecial Presentation for the Naifeh FamilyArvind Bhimaraj, MD, MPH, FACC, FHFSA
R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed)
Barry H. Trachtenberg, MD, FACC
Susan A. Zylicz, BSN, MHA, CCTC
8:35 AMA Message from the Naifeh FamilyValerie Naifeh
PLENARY SESSION I: WHAT IS AMYLOIDOSIS?
8:45 AMWhat Is Amyloidosis and What is the Clinical Relevance?Arvind Bhimaraj, MD, MPH, FACC, FHFSA
9:00 AMUnderstanding AL Amyloidosis-Clinical Presentations and Biological Implications of a Multisystem DiseaseVaishali Sanchorawala, MD
9:25 AMRecognizing TTR and Diagnostic Work Up for Cardiac AmyloidosisBarry H. Trachtenberg, MD, FACC
9:40 AMQ&A and Discussion
9:55 AMBREAK AND EXHIBITS
PLENARY SESSION II: COURSE OF ACTION: THE CURRENT AND FUTURE OF TREATMENT
10:10 AMCurrent Treatment Options for AL AmyloidosisKelty R. Baker, MD
10:25 AMCurrent and Future Treatment Options for TTR Amyloidosis
Novel Therapies in Amyloidosis: Anti-Fibrils Strategies 
Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM 
10:50 AMFDA Perspective on New TherapiesRosalyn Adigun, MD, PharmD
11:10 AMQ&A and Discussion
11:25 AMLUNCH AND EXHIBITS
PLENARY SESSION III: AMYLOIDOSIS AND ORGAN INVOLVEMENT: HOW IT ALL RELATES 
12:25 PMAmyloidosis in the Neurology World: Neuropathies, Autonomic Dysfunction and MoreSheetal Shroff, MBBS
12:40 PMGastrointestinal Involvement and Management in AmyloidosisElizabeth Blaney, MD
1:05 PMRole of Orthopedic Providers for Early Diagnosis of AmyloidosisShari R. Liberman, MD
1:20 PMRenal Involvement in AmyloidosisHoracio E. Adrogue, MD, FASN
1:35 PMLung Involvement in Amyloidosis 
1:50 PMSolid Organ Replacement of End Organs in Amyloidosis: A Viable Option in Select Centers 
2:10 PMQ&A and Discussion 
2:25 PMBREAK AND EXHIBITS
PLENAEY SESSION IV: CASE-BASED LEARNING: AMYLOIDOSIS - AN ELUSIVE DISEASE
2:40 PMCase Presentation (Cardiac): Cardiogenic Shock and Bridge to TransplantPresenter: Houston Methodist Fellow
Panel: Houston Methodist Faculty
3:05 PMClosing Remarks
3:15 PMAdjourn
LIVESTREAM (Virtual)

 

 

COURSE DIRECTORS
Arvind Bhimaraj, MD, MPH, FACC, FHFSA
Co-Director, Bradley Z. Naifeh Treatment and Research Program
Associate Professor, Weill Cornell Medical School
Co-Director, Heart Failure and Transplantation Translational Laboratory
Director, Heart Failure Disease Management Service
Division of Heart Failure, Transplantation and Mechanical Circulatory Support Cardiology
Methodist DeBakey Cardiology Associates
Barry H. Trachtenberg, MD, FACC
Co-Director, Bradley Z. Naifeh Treatment and Research Program
Advanced Heart Failure and Transplantation
Member, Methodist Heart and Vascular Center
Houston Methodist J.C. Walter Jr. Transplant Center
Houston Cardiovascular Associates
Heart Failure Co-Chair, Texas Chapter American College of Cardiology
 
SPECIAL GUEST
Valerie Naifeh
 
GUEST FACUTLY
Rosalyn Adigun, MD, PharmD, MSc
Medical Officer
Division of Cardiology and Nephrology
U.S. Food and Drug Administration
Silver Spring, Maryland
Elizabeth Blaney, MD
Associate Professor of Medicine
Division of Gastroenterology
Associate Program Director of Education
Washington University School of Medicine
St. Louis, Missouri
Vaishali Sanchorawala, MD
Professor of Medicine
Director, Amyloidosis Center
Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine
Boston, Massachusetts
Professor Ashutosh Wechalekar, MD, FRCP, FRCPath, DM
Professor of Medicine and Haematology
Consultant Haematologist
Director, Jack O’Neil Amyloidosis Laboratory
National Amyloidosis Centre|University College London (Royal Free Campus)
Department of Haematology, University College London Hospitals
Department of Haematology, Royal Free London NHS Foundation Trust
London, England
 
HOUSTON METHODIST FACULTY
Horacio E. Adrogue, MD, FASN
Associate Professor of Clinical Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Kelty R. Baker, MD
Hematologic Malignancy, Hematology
Houston Methodist
A. Osama Gaber, MD, FACS, FAST
John F., Jr. and Carolyn Bookout Presidential Distinguished Chair in Surgery, Department of Surgery
Chair, Department of Surgery
Professor of Surgery
Program Director, Transplant Surgery Fellowship, Department of Surgery
Houston Methodist
Weill Cornell Medical College
R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed)
J.C. Walter Jr. Presidential Distinguished Chair
Director, J.C. Walter Jr. Transplant Center
Director, Transplantation Research
Chief, Division of Transplantation, Department of Surgery
Professor of Surgery
Weill Cornell Medical College
Houston Methodist
Shari R. Liberman, MD
Hand & Upper Extremity Surgery
Henrietta and Terence Hall Distinguished Centennial Clinical Academic Scholar in Orthopedic Surgery
Program Director, Houston Methodist Department of Orthopedic Surgery
Assistant Professor for Clinical Orthopedic Surgery, Weill Cornell Medical College
Assistant Professor for Clinical Orthopedic Surgery, Texas A & M College of Medicine
Sheetal Shroff, MBBS
Assistant Professor of Clinical Neurology, Academic Institute
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College

Available Credit

  • 4.75 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 4.75 Attendance
  • 5.00 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 5.00 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

  • 4.00 Social Work
    The program has been approved for 4.00 CE contact hours for Social Workers through the Texas State Board of Social Work Examiners.
  • 0.00 Transplant Coordinators
    The American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Bradley Z. Naifeh Inaugural Amyloidosis Conference - Medical Professionals - LIVESTREAM (VIRTUAL ONLY) | Tue, 01/03/2023 - 8:00am | 0.00 Category 1 CEPTCs

Price

Cost:
$230.00
Please login or register to take this course.

STEPS TO REGISTER:

  • STEP 1 - Choose the appropriate fee and click the "Add to Cart" button to complete the checkout process. 
  • STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.

FEES

REGISTRATION TYPEFEE
Physician (HM, MPAQ, ACO PCP) Complimentary
Physician (Private physician located within the Greater Houston Area)$230
Physician (Private physician located within the Greater Houston Area; NO CE) Click here to register!Complimentary
Physician (Private physician located outside the Greater Houston Area)Complimentary
Allied Health Care Professionals Complimentary
Resident / Fellow / Student Complimentary

* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.